EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Faecal microbiota transplantation from young rats attenuates age‐related sarcopenia revealed by multiomics analysis

Xiaoxing Mo, Lihui Shen, Ruijie Cheng, Pei Wang, Lin Wen, Yunhong Sun, Qiang Wang, Juan Chen, Shan Lin, Yuxiao Liao, Wei Yang, Hong Yan und 1 weitere

Journal of Cachexia, Sarcopenia and Muscle · 2023

DOI: 10.1002/jcsm.13294 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cachexia, Sarcopenia and Muscle, 2023. Verfasst von Xiaoxing Mo und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition and Food Hygiene, Hubei Key Laboratory of Food Nutrition and Safety, MOE Key Lab of Environment and Health, School of Public …. Hauptthemen laut MEDLINE: Sarcopenia, Fecal Microbiota Transplantation, Aging. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Angel Nutrition Research Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Gut microbiota plays a key role in the development of sarcopenia via the ‘gut‐muscle’ axis, and probiotics‐based therapy might be a strategy for sarcopenia. Fecal microbiota transplantation from young donors (yFMT) has attracted much attention because of its probiotic function. However, whether or not yFMT is effective for sarcopenia in old recipients is largely unknown. Thus, we aimed to investigate the effect and mechanism of yFMT on age‐related sarcopenia.

Methods

The fecal microbiota of either young (12 weeks) or old (88 weeks) donor rats was transplanted into aged recipient rats for 8 weeks. Then, muscle mass, muscle strength, muscle function, muscle atrophy, and muscle regeneration capacity were measured. Analysis of fecal 16 s rRNA, serum non‐targeted metabolomic, gut barrier integrity, and muscle transcriptome was conducted to elucidate the interaction between gut microbiota and skeletal muscles.

Results

As evaluated by magnetic resonance imaging examination, grip strength test ( P < 0.01), rotarod test ( P < 0.05), and exhaustive running test ( P < 0.05), we found that yFMT mitigated muscle mass loss, muscle strength weakness, and muscle function impairment in aged rats. yFMT also countered age‐related atrophy and poor regeneration capacity in fast‐ and slow‐switch muscles, which were manifested by the decrease in slow‐switch myofibres (both P < 0.01) and muscle interstitial fibrosis (both P < 0.05) and the increase in the cross‐section area of myofibres (both P < 0.001), fast‐switch myofibres (both P < 0.01), and muscle satellite cells (both P < 0.001). In addition, yFMT ameliorated age‐related dysbiosis of gut microbiota and metabolites by promoting the production of beneficial bacteria and metabolites— Akkermansia , Lactococcus , Lactobacillus , γ‐glutamyltyrosine, 3R‐hydroxy‐butanoic acid, and methoxyacetic acid and inhibiting the production of deleterious bacteria and metabolites— Family_XIII_AD3011_group , Collinsella , indoxyl sulfate, indole‐3‐carboxilic acid‐ O ‐sulphate, and trimethylamine N‐oxide. Also, yFMT prevented age‐related destruction of gut barrier integrity by increasing the density of goblet cells ( P < 0.0001) and the expression levels of mucin‐2 ( P < 0.0001) and tight junctional proteins (all P < 0.05). Meanwhile, yFMT attenuated age‐related impairment of mitochondrial biogenesis and function in fast‐ and slow‐switch muscles. Correlation analysis revealed that yFMT‐induced alterations of gut microbiota and metabolites might be closely related to mitochondria‐related genes and sarcopenia‐related phenotypes. Conclusions yFMT could reshape the dysbiosis of gut microbiota and metabolites, maintain gut barrier integrity, and improve muscle mitochondrial dysfunction, eventually alleviating sarcopenia in aged rats. yFMT might be a new therapeutic strategy for age‐related sarcopenia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcopeniaFecal Microbiota TransplantationAgingAnimalsRatsGastrointestinal MicrobiomeMaleMuscle, SkeletalDisease Models, AnimalMultiomics

Stichwörter der Autor:innen

Fecal microbiota transplantationGut microbiotaMetabolitesMitochondrial dysfunctionMuscleSarcopenia

Autor:innen und Institutionen

  • Department of Nutrition and Food Hygiene, Hubei Key Laboratory of Food Nutrition and Safety, MOE Key Lab of Environment and Health, School of Public Health, Tongji Medical College, Huazhong University of Science and Tec…
  • Department of Health Toxicology, MOE Key Lab of Environment and Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Förderung

  • National Natural Science Foundation of China
  • Angel Nutrition Research Fund

Zitieren

APA

Mo, X., Shen, L., Cheng, R., Wang, P., Wen, L., Sun, Y., Wang, Q., Chen, J., Lin, S., Liao, Y., Yang, W., Yan, H., & Liu, L. (2023). Faecal microbiota transplantation from young rats attenuates age‐related sarcopenia revealed by multiomics analysis. Journal of Cachexia, Sarcopenia and Muscle. https://doi.org/10.1002/jcsm.13294

Vancouver

Mo X, Shen L, Cheng R, Wang P, Wen L, Sun Y, et al. Faecal microbiota transplantation from young rats attenuates age‐related sarcopenia revealed by multiomics analysis. Journal of Cachexia, Sarcopenia and Muscle. 2023. doi:10.1002/jcsm.13294

BibTeX
@article{Mo2023,
  author = {Mo, Xiaoxing and Shen, Lihui and Cheng, Ruijie and Wang, Pei and Wen, Lin and Sun, Yunhong and Wang, Qiang and Chen, Juan and Lin, Shan and Liao, Yuxiao and Yang, Wei and Yan, Hong and Liu, Liegang},
  title = {Faecal microbiota transplantation from young rats attenuates age‐related sarcopenia revealed by multiomics analysis},
  journal = {Journal of Cachexia, Sarcopenia and Muscle},
  year = {2023},
  doi = {10.1002/jcsm.13294}
}
Kostenlos starten →